NeoGenomics (NEO) Chief Accounting Officer Greg Aunan Sells 20,000 Shares

What Happened
Greg D. Aunan, Chief Accounting Officer of NeoGenomics, reported an open-market sale of 20,000 shares on August 4, 2026 at $16.07 per share, generating proceeds of approximately $321,400. This filing reports a sale (S), which is often a routine liquidity event rather than a direct signal about company prospects.

Key Details

• Transaction date and price: August 4, 2026 — 20,000 shares sold at $16.07 each. Total proceeds ≈ $321,400.
• Transaction type: Open-market sale (coded "S" on the Form 4).
• Shares owned after transaction: Not specified in the provided filing summary (see the full Form 4 for post-sale holdings).
• Filing date: Form 4 filed Aug 6, 2026 — appears timely (filed within the usual 2-business-day window).
• Notable footnotes: The filing lists multiple prior grants to Mr. Aunan (restricted stock units and stock options granted in 2023, 2024, 2025 and March 1, 2026) with vesting schedules noted; see footnotes for details on vesting.

Context
Sales by executives can be for many reasons (diversification, taxes, personal liquidity) and are common; they do not necessarily indicate changed views on company fundamentals. The footnotes show Mr. Aunan has received RSU and option grants with multi-year vesting schedules — the sale may have involved previously vested shares, but the filing does not specify the source of the sold shares. For full holdings and transaction provenance, review the complete Form 4 filing (Accession: 0001646370-26-000002).